Rodriguez and colleagues demonstrated that CAR-T cells specific for human FRβ specifically recognize and delete M2-like FRβ+ TAMs and enhance the anti-tumor efficiency of CAR-T cells (199). The gene discussed is FOLR2; the disease is neoplasm.